ReviewPharmaceutics2021
Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream.
Paul Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it
ReviewPharmaceutics2021
Paul Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.